Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT
2006

Dexamethasone Protects MCF-7 Cells from TNF-alpha-Induced Cell Death

publication 10 minutes Evidence: moderate

Author Information

Author(s): Machuca Catalina, Mendoza-Milla Criselda, Córdova Emilio, Mejía Salvador, Covarrubias Luis, Ventura José, Zentella Alejandro

Primary Institution: Facultad de Estudios Superiores ZARAGOZA, UNAM

Hypothesis

Does dexamethasone provide protection against TNF-alpha-induced cell death in MCF-7 cells through NF-kappaB activation?

Conclusion

Dexamethasone protects MCF-7 cells from TNF-alpha-induced cell death by requiring NF-kappaB activation and is independent of the PI3K/Akt pathway.

Supporting Evidence

  • Dexamethasone completely abrogated TNF-alpha-mediated cell death in MCF-7 cells.
  • Inhibition of NF-kappaB activity led to loss of dexamethasone protection.
  • PI3K/Akt pathway inhibition did not affect dexamethasone's protective effect.

Takeaway

Dexamethasone helps breast cancer cells survive when they are attacked by a harmful substance called TNF-alpha, and it does this by using a special protein pathway.

Methodology

MCF-7 cells were treated with TNF-alpha and dexamethasone, and cell viability was assessed using crystal violet assays, along with Western blot analysis for protein expression.

Limitations

The study primarily focuses on a single cell line, which may not fully represent the complexity of breast cancer in patients.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2121-7-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication